Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder

Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder

Antidepressant therapies, such as selective serotonin reuptake inhibitors (SSRIs), are current first-line treatments for Major Depressive Disorder. However, over 50% of treated patients show an inadequate response to initial antidepressant therapy. If the therapeutic outcomes from two antidepressant...

Full description

Bibliographic Details
Main Authors: Allan H. Young, Holly MacPherson, Rubo J. Seo
Format: Article
Language:English
Published: MDPI AG 2010-12-01
Series:Pharmaceuticals
Subjects:
treatment resistant disorder
major depressive disorder
augmentation
atypical antipsychotic
typical antipsychotic
antidepressant
selective serotonin reuptake inhibitor
electroconvulsive therapy
Online Access:http://www.mdpi.com/1424-8247/3/12/3522/

Internet

http://www.mdpi.com/1424-8247/3/12/3522/

Similar Items